Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5728404

NCCOc1cc(=O)oc2ccc(Cl)cc12.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ HTR2C P28335 2/20 0.44
▸ ALDH1A1 P00352 6/20 0.42
▸ KCNA3 P22001 1/20 0.42
▸ MAOB P27338 1/20 0.40
▸ MCL1 Q07820 3/20 0.39
▸ TTR P02766 1/20 0.39
▸ KDM4E B2RXH2 4/20 0.38
▸ HPGD P15428 3/20 0.38
▸ TSHR P16473 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ PPARA Q07869 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3913356 0.94 HTR2C (0.45) HTR2CALDH1A1KCNA3MAOBMCL1
Trifluoroacetic Acid SCHEMBL3923252 0.93 KCNA3 (0.46) HTR2CALDH1A1KCNA3MAOBMCL1
Trifluoroacetic Acid SCHEMBL3925125 0.92 KCNA3 (0.45) HTR2CALDH1A1KCNA3MAOBMCL1
SCHEMBL3915228 0.89 KCNA3 (0.47) ALDH1A1KCNA3MAOBTSHR
Trifluoroacetic Acid SCHEMBL3910499 0.86 ALDH1A1 (0.51) HTR2CALDH1A1KCNA3MCL1KDM4E
Trifluoroacetic Acid SCHEMBL3911993 0.85 KCNA3 (0.60) ALDH1A1KCNA3MAOBTSHR
Trifluoroacetic Acid SCHEMBL3912558 0.84 HTR2C (0.39) HTR2CALDH1A1KCNA3MAOBMCL1
SCHEMBL3911254 0.83 KCNA3 (0.49) ALDH1A1KCNA3MAOBMCL1TSHR
Trifluoroacetic Acid SCHEMBL3913747 0.82 KCNA3 (0.44) KCNA3
SCHEMBL3920121 0.82 KCNA3 (0.51) ALDH1A1KCNA3MAOBTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1667988-B1 COUMARINS AS INOS INHIBITORS AVENTIS PHARMA INC (US) 2013-04-10 — — EP disclosed
EP-1667988-A1 COUMARINS AS INOS INHIBITORS Aventis Pharmaceuticals Inc. (US) 2006-06-14 — — EP disclosed
WO-2005026143-A1 COUMARINS AS INOS INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2005-03-24 — — WO disclosed
Send feedback